Professor, Department of Pharmaceutics at (NIPER), Punjab
Dr Arvind Kumar Bansal is currently Professor, department of Pharmaceutics at National Institute of Pharmaceutical Education and Research (NIPER) – SAS Nagar, Punjab, India. He earned his M Pharm (Pharmaceutics) (1988) and Ph.D. (1993) from University of Delhi, India.
Prof Bansal worked as Senior Scientist and Group Leader in JK Pharmaceuticals and Ranbaxy Research Laboratories, for 8 years. Therein he conceptualised, evolved formulation strategies, developed and transferred the technology to production shop floor, for NCEs and generic drug products.
Prof Bansal joined NIPER in 2000 and has developed expertise in areas of pre-formulation and formulation development encompassing characterization and stabilization of the amorphous form, polymorphism, pseudo-polymorphism, particle engineering, screening salt forms, improvement of oral bioavailability and lyophilization. His research group works with the mission statement – ‘developing science based industrially viable pharmaceutical technologies’ and works closely with pharmaceutical industry to create opportunities for commercial exploitation of the products.
Dr Bansal was conferred prestigious Fellow of American Association of Pharmaceutical Sciences in 2016. He is the first Indian working India being awarded this Fellow status. He has won prestigious awards like AAiPS Distinguished Educator and Researcher Award, Innocentive Award and OPPI Award.
Prof Bansal’s research group has completed nearly 700 industry sponsored projects, granted 08 patents, filed 27 patents, and published ~225 research articles and 26 review articles. He is an editorial board member of Journal of Excipients and Food Chemicals and Pharmaceutics. He is also an Advisor to the editorial board of Journal of Pharmaceutical Sciences and on Editorial Board of Molecular Pharmaceutics. His lab has out-licensed a platform technology on “Nano crystalline solid dispersions – NanoCrySP.
National Scientific Committee
